CONMED Corporation (CNMD)
NYSE: CNMD · IEX Real-Time Price · USD
75.08
+0.36 (0.48%)
May 20, 2024, 2:35 PM EDT - Market open

CONMED Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 1994
Revenue
1,2451,0451,011862.46955.1
Upgrade
Revenue Growth (YoY)
19.06%3.45%17.18%-9.70%11.11%
Upgrade
Cost of Revenue
568.5474.23442.6402.16430.38
Upgrade
Gross Profit
676.25571.25568.04460.3524.72
Upgrade
Selling, General & Admin
503.04454.04414.75373.82400.14
Upgrade
Research & Development
52.647.1543.5740.4745.46
Upgrade
Other Operating Expenses
0112.011.130.365.19
Upgrade
Operating Expenses
555.64613.2459.45414.65450.79
Upgrade
Operating Income
120.6-41.96108.5945.6673.93
Upgrade
Interest Expense / Income
39.7828.9135.4944.0542.7
Upgrade
Pretax Income
80.83-70.8673.111.631.23
Upgrade
Income Tax
16.379.7210.56-7.912.61
Upgrade
Net Income
64.46-80.5862.549.5228.62
Upgrade
Net Income Growth
--557.16%-66.75%-29.95%
Upgrade
Shares Outstanding (Basic)
3130292928
Upgrade
Shares Change
0.89%4.22%2.26%0.78%0.89%
Upgrade
EPS (Basic)
2.10-2.682.140.331.01
Upgrade
EPS (Diluted)
2.04-2.681.940.320.97
Upgrade
EPS Growth
--506.25%-67.01%-31.21%
Upgrade
Free Cash Flow
106.3211.5896.954.7575.07
Upgrade
Free Cash Flow Per Share
3.460.383.311.912.65
Upgrade
Dividend Per Share
0.8000.8000.8000.8000.800
Upgrade
Gross Margin
54.33%54.64%56.21%53.37%54.94%
Upgrade
Operating Margin
9.69%-4.01%10.74%5.29%7.74%
Upgrade
Profit Margin
5.18%-7.71%6.19%1.10%3.00%
Upgrade
Free Cash Flow Margin
8.54%1.11%9.59%6.35%7.86%
Upgrade
Effective Tax Rate
20.25%-14.45%-493.70%8.34%
Upgrade
EBITDA
136.8-25.9125.0863.792.61
Upgrade
EBITDA Margin
10.99%-2.48%12.38%7.39%9.70%
Upgrade
Depreciation & Amortization
16.216.0616.4918.0418.69
Upgrade
EBIT
120.6-41.96108.5945.6673.93
Upgrade
EBIT Margin
9.69%-4.01%10.74%5.29%7.74%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).